RXO: the cash flow

MyFinsight

For the year ending 2025-12-31, RXO had -$17M decrease in cash & cash equivalents over the period. -$8M in free cash flow.

Cash Flow	2025-12-31
Net income (loss)	-100
Depreciation and amortization expense	116
Stock compensation expense	29
Deferred tax benefit	-21
Deemed non-pro rata distribution	0
Impairment of operating lease assets	4
Goodwill impairment	12
Other	-11
Accounts receivable	5
Other current assets and other long-term assets	-19
Accounts payable	-16
Accrued expenses, other current liabilities and other long-term liabilities	2
Net cash provided by (used in) operating activities	51
Payment for purchases of property and equipment	59
Business acquisition, net of cash acquired	10
Proceeds from sale of property and equipment	2
Other	4
Net cash used in investing activities	-71
Proceeds from borrowings on revolving credit facilities	566
Repayment of borrowings on revolving credit facilities	533
Proceeds from issuance of common stock and pre-funded warrants	0
Payment for equity issuance costs	1
Repayment of debt and finance leases	2
Payment for debt issuance costs	0
Payment for tax withholdings related to vesting of stock compensation awards	19
Repurchase of common stock	0
Other	-10
Net cash provided by (used in) financing activities	1
Effect of exchange rates on cash, cash equivalents and restricted cash	2
Net increase (decrease) in cash, cash equivalents and restricted cash	-17
Cash and cash equivalents at beginning of period	35
Cash and cash equivalents at end of period	18

Unit: Million (M) dollars (except for numbers of shares and EPS).